Video Experimental Relacionado
Updated: Sep 10, 2025
09:23
Delivery of the Cas9/sgRNA Ribonucleoprotein Complex in Immortalized and Primary Cells via Virus-like Particles "Nanoblades"
Published on: March 31, 2021
5.1K
La nanoterapia de JEV autorreplicante programable redefine la entrega de ARN en la ELA
Yan Shan Loo1, Nur Aininie Yusoh2, Keyin Yap1
1School of Science, Monash University Malaysia, Jalan Lagoon Selatan, Selangor, Malaysia.
Communications biology
|August 26, 2025
Resumen
El virus de la encefalitis japonesa (JEV) diseñado podría entregar oligonucleótidos antisenso (ASO) a las neuronas motoras para tratar la esclerosis lateral amiotrófica (ELA). Esta nueva estrategia de nanocarrier apunta a una terapia génica dirigida y sostenida a través de la barrera hematoencefálica.
Área de la Ciencia:
- La neurociencia
- Virología
- Terapia génica
Sus antecedentes:
- La esclerosis lateral amiotrófica (ELA) es una enfermedad neurodegenerativa fatal con opciones de tratamiento limitadas.
- La administración efectiva de fármacos al sistema nervioso central (SNC) es un obstáculo importante para la terapia génica de ELA.
- Los oligonucleótidos antisenso (ASO) y CRISPR/Cas9 son prometedores, pero requieren de vectores de entrega eficientes.
Objetivo del estudio:
- Proponer una nueva estrategia para la administración terapéutica dirigida a las neuronas motoras en el SNC.
- Explorar el uso del virus de la encefalitis japonesa modificado (JEV) como nanotransportador para la administración de ASO.
- Para superar las barreras hematoencefálicas y hematoespinales (BBB/BSCB) para mejorar la terapia génica en enfermedades neurodegenerativas.
Principales métodos:
- Diseñar el virus de la encefalitis japonesa (JEV) para que actúe como un nanotransportador autorreplicante.
- Incorporación de secuencias de oligonucleótidos antisenso (ASO) en el genoma JEV para el empaque conjunto.
- Utilizando el neurotropismo natural de JEV y la entrada mediada por células inmunes para la orientación del SNC.
- Utilizando la atenuación mediada por microARN (miRNA) para mejorar la seguridad y la especificidad del SNC.
Principales resultados:
- El sistema nanocarrier basado en JEV propuesto permite teóricamente la entrega de ASO dirigida a las neuronas motoras.
- Este enfoque aprovecha las propiedades de JEV para eludir el BBB/BSCB, facilitando la penetración en el SNC.
- El coenvasado de ASO dentro del genoma de JEV permite una liberación terapéutica sostenida.
Conclusiones:
- El JEV diseñado presenta un posible cambio de paradigma para la terapia génica del SNC en ELA y otras afecciones neurodegenerativas.
- Esta estrategia ofrece un marco teórico para una entrega de ASO eficiente, dirigida y sostenida.
- La validación experimental es crucial para confirmar la seguridad y la eficacia terapéutica de este enfoque.
Más Videos Relacionados
Videos de Conceptos Relacionados
01:23RNA Interference
26.4K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.4K
01:29Viruses with RNA Genomes
118
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
118
02:15Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
02:30siRNA - Small Interfering RNAs
17.0K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.0K
02:27Nonsense-mediated mRNA Decay
2.9K
2.9K
01:21Satellite Stem Cells and Muscular Dystrophy
2.0K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.0K